Webinar Date/Time: Tue, Feb 21, 2023 11:00 AM EST
Heightened regulatory scrutiny from clinical trial governing agencies has created the need for sponsors to understand their IRT audit data more completely and create a plan for management. Join Endpoint Clinical’s VP of Data and Quality, Cat Hall, as she dives into IRT audit log data, the regulations and guidelines, and top things to consider when building your IRT Audit Data Management Plan.
Register Free:
https://globalmeet.webcasts.com/starthere.jsp?ei=1593748&tp_key=3d9334f8d1
Event Overview:
In recent years, there has been an increase in regulatory scrutiny from clinical trial governing agencies, with a particular focus on the validation of computer systems and the need for verification of data integrity and reliability through audit trail review. This heightened attention has created the need for sponsors to understand their IRT audit data more completely and create a plan for management. Join Endpoint Clinical’s VP of Data and Quality, Cat Hall, as she dives into IRT audit log data, the regulations and guidelines, and top things to consider when building your IRT Audit Data Management Plan.
Key Learning Objectives:
Speakers:
Catherine Hall
VP, Data and Quality
Endpoint Clinical
Cat Hall started her career as an Academic Scientist before finishing her MBA and transitioning into pharmaceutical supply chain management. Cat has developed notable expertise not only in clinical supplies but also in training development, process improvement, managing partnerships, and the design and implementation of technologies such as IRT. She is well-known for focusing on bridging the GMP/GCP gap by bringing supply chain customer service through the last mile to patients. Cat joined Endpoint in 2019 as VP of Product Strategy, and currently serves as VP of Data and Quality.
Register Free:
https://globalmeet.webcasts.com/starthere.jsp?ei=1593748&tp_key=3d9334f8d1
What Can ClinOps Learn from Pre-Clinical?
August 10th 2021Dr. Hanne Bak, Senior Vice President of Preclinical Manufacturing and Process Development at Regeneron speaks about her role at the company as well as their work with monoclonal antibodies, the regulatory side of manufacturing, and more.